Atenolol
- Product NDC
- 53002-2138
- 11-digit product format
- 530022138
- Labeler code
- 53002
- Product ID
- 53002-2138_28bf5d7e-afee-4c73-93bf-f4e6af05df04
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atenolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA077443
- Marketing category
- ANDA
- Marketing start
- 2010-06-10
- Marketing end
- 0000-00-00
- Substance
- ATENOLOL
- Active strength
- 100 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-2138-0 | Atenolol | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
| 53002-2138-3 | Atenolol | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 53002-2138-6 | Atenolol | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-2138 | ATENOLOL TABLET [RPK PHARMACEUTICALS, INC.] | 1 | Legacy NDC, 3 package rows | 20220331_92319404-c8af-45cd-b768-b62ca8204ba0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-2138-0 | 53002213800 | 100 TABLET in 1 BOTTLE (53002-2138-0) | 100 tablet | 2021-01-01 | 0000-00-00 | No | No | Current |
| 53002-2138-3 | 53002213803 | 30 TABLET in 1 BOTTLE (53002-2138-3) | 30 tablet | 2021-01-01 | 0000-00-00 | No | No | Current |
| 53002-2138-6 | 53002213806 | 60 TABLET in 1 BOTTLE (53002-2138-6) | 60 tablet | 2021-01-01 | 0000-00-00 | No | No | Current |